Study to Characterize the Distribution of Lipoprotein(a) Levels Among Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Atherosclerotic Cv Disease
  • Age: Between 18 years - 85 years
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Can provide informed consent prior to initiation of any study specific activities/procedures.
    2. History of ASCVD.
    3. Multivessel PCI.

You may not be eligible for this study if the following are true:

    1. Known to be currently receiving investigational drug in a clinical study that is anticipated to last > 1 year.
    2. Known Lp(a) value < 90 mg/dL (if measured in mass) or < 200 nmol/L (if measured in molar).
    3. Diagnosis of end-stage renal disease or requires dialysis.
    4. Poorly controlled diabetes mellitus.
    5. Receiving or has received lipoprotein apheresis to reduce Lp(a) within 3 months prior to enrollment.
    6. Known uncontrolled or recurrent ventricular tachycardia in the past 3 months prior to enrollment.
    7. Known malignancy (except non-melanoma skin cancers, cervical in situ carcinoma, breast ductal carcinoma in situ, or stage 1 prostate carcinoma) within the last 5 years prior to enrollment.
    8. Known history or evidence of clinically significant disease (eg, respiratory, gastrointestinal, or psychiatric disease) or unstable disorder or biomarker that would result in life expectancy < 5 years.
    9. Known hemorrhagic stroke.

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.